Advanced search
Publication Cover
International Reviews of Immunology Volume 21, 2002 - Issue 1
Submit an article Journal homepage
105
Views
44
CrossRef citations to date
0
Altmetric
Research Article

THE MOLECULAR CONTROL OF ANGIOGENESIS

OLIVER DISTLER WHO Collaborating Center for Molecular Biology and Novel Therapeutic Strategies for Rheumatic Diseases, University Hospital Zurich, Zurich, Switzerland
,
MICHEL NEIDHART WHO Collaborating Center for Molecular Biology and Novel Therapeutic Strategies for Rheumatic Diseases, University Hospital Zurich, Zurich, Switzerland
,
RENATE E. GAY WHO Collaborating Center for Molecular Biology and Novel Therapeutic Strategies for Rheumatic Diseases, University Hospital Zurich, Zurich, Switzerland
&
STEFFEN GAY WHO Collaborating Center for Molecular Biology and Novel Therapeutic Strategies for Rheumatic Diseases, University Hospital Zurich, Zurich, Switzerland
Pages 33-49 | Published online: 03 Aug 2009

  • H.M. Kwon, G. Sangiorgi, E.L. Ritman, C. McKenna, D.R. Holmes Jr., R.S. Schwartz et al., Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J. Clin. Invest., 101(8): 1551-1556, 1998.
  • K.S. Moulton, E. Heller, M.A. Konerding, E. Flynn, W. Palinski and J. Folkman, Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation, 99(13): 1726-1732, 1999.
  • A.E. Koch, The role of angiogenesis in rheumatoid arthritis: Recent developments. Ann. Rheum. Dis., 59(Suppl 1): 165-171, 2000.
  • A.J. Hayes, Angioneogenesis in rheumatoid arthritis. Lancet, 354(9176): 423-424, 1999.
  • S. Hirohata and J. Sakakibara, Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis. Lancet, 353(9161): 1331, 1999.
  • M. Neidhart, R. Wehrli, P. Bruhlmann, B.A. Michel, R.E. Gay and S. Gay, Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Arthritis Rheum, 42(4): 622-630, 1999.
  • J. Lu, T. Kasama, K. Kobayashi, Y. Yoda, F. Shiozawa, M. Hanyuda et al., Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J. Immunol., 164(11): 5922-5927, 2000.
  • E.G. LeRoy, Systemic sclerosis. A vascular perspective. Rheum. Dis. Clin. North Am., 22(4): 675-694, 1996.
  • O. Distler, A. Scheid, O. Kowal-Bielecka, J. Schedel, J. Rethage, A. Carossino et al., Expression and regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) in systemic sclerosis. Arthritis Rheum, 42: S203, 2000.
  • R. Sgonc, M.S. Gruschwitz, G. Boeck, N. Sepp, J. Gruber and G. Wick, Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum, 43(11): 2550-2562, 2000.
  • R. Sgonc, M.S. Gruschwitz, H. Dietrich, H. Recheis, M.E. Gershwin and G. Wick, Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J. Clin. Invest., 98(3): 785-792, 1996.
  • C. Lunardi, C. Bason, R. Navone, E. Millo, G. Damonte, R. Corrocher et al., Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat. Med., 6(10): 1183-1186,2000.
  • M. Peichev, A.J. Naiyer, D. Pereira, Z. Zhu, W.J. Lane, M. Williams et al., Expression of VEGFR-2 and AC133 by circulating human CD34( + ) cells identifies a population of functional endothelial precursors. Blood. 95(3): 952-958, 2000.
  • T. Takahashi, C. Kalka, H. Masuda, D. Chen, M. Silver, M. Kearney et al., Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med., 5(4): 434-438, 1999.
  • T. Asahara, T. Takahashi, H. Masuda, C. Kalka, D. Chen, H. Iwaguro et al., VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J., 18(14): 3964-3972, 1999.
  • T. Asahara, H. Masuda, T. Takahashi, C. Kalka, C. Pastore, M. Silver et al., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res., 85(3): 221-228, 1999.
  • P. Carmeliet, Mechanisms of angiogenesis and arteriogenesis. Nat. Med., 6(4): 389-395, 2000.
  • G.D. Yancopoulos, S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand and J. Holash, Vascular-specific growth factors and blood vessel formation. Nature, 407(6801): 242-248, 2000.
  • M. Ziehe, L. Morbidelli, R. Choudhuri, H.T. Zhang, S. Donnini, H.J. Granger et al., Nitric oxide synthase lies downstream from vascular endothelial growth factorinduced but not basic fibroblast growth factor-induced angiogenesis. J. Clin. Invest., 99(11): 2625-2634, 1997.
  • D.R. Senger, S.J. Galli, A.M. Dvorak, C.A. Perruzzi, VS. Harvey and H.F. Dvorak, Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science, 219(4587): 983-985, 1983.
  • S. Kohn, J.A. Nagy, H.F. Dvorak and A.M. Dvorak, Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab. Invest., 67(5): 596-607, 1992.
  • H.F. Dvorak, L.F. Brown, M. Detmar and A.M. Dvorak, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol, 146(5): 1029-1039, 1995.
  • B.P. Eliceiri, R. Paul, RL Schwartzberg, J.D. Hood, J. Leng and D.A. Cheresh, Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. MoI. Cell, 4(6): 915-924, 1999.
  • W.G. Stetler-Stevenson, Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J. Clin. Invest., 103(9): 1237-1241, 1999.
  • N. Hiraoka, E. Allen, I.J. Apel, M.R. Gyetko and S.J. Weiss, Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell, 95(3): 365-377, 1998.
  • T.L. Haas, S.J. Davis and J.A. Madri, Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MTl-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem., 273(6): 3604-3610, 1998.
  • A.E. Koch, Review: Angiogenesis: Implications for rheumatoid arthritis. Arthritis Rheum., 41(6): 951-962, 1998.
  • P. Carmeliet, V Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein et al., Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380(6573): 435-439, 1996.
  • N. Ferrara, K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K.S. O'Shea et al., Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380(6573): 439-442, 1996.
  • F. Shalaby, J. Rossant, TP. Yamaguchi, M. Gertsenstein, X.F. Wu, M.L. Breitman et al., Failure of blood-island formation and vasculogenesis in FIk-1-deficient mice. Nature, 376(6535): 62-66, 1995.
  • G.H. Fong, J. Rossant, M. Gertsenstein and M.L. Breitman, Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature, 376(6535): 66-70, 1995.
  • L. Miquerol, B.L. Langille and A. Nagy, Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development, 127(18): 3941-3946, 2000.
  • H.P. Gerber, T.H. Vu, A.M. Ryan, J. Kowalski, Z. Werb and N. Ferrara, VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med., 5(6): 623-628, 1999.
  • N. Ferrara, H. Chen, T. Davis-Smyth, H.P. Gerber, T.N. Nguyen, D. Peers et al., Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat. Med., 4(3): 336-340, 1998.
  • S. Soker, S. Takashima, H.Q. Miao, G. Neufeld and M. Klagsbrun, Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell, 92(6): 735-745, 1998.
  • B. Olofsson, K. Pajusola, A. Kaipainen, G. von Euler, V. Joukov, O. Saksela et al., Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. USA, 93(6): 2576-2581, 1996.
  • B. Olofsson, E. Korpelainen, M.S. Pepper, S.J. Mandriota, K. Aase, V. Kumar et al., Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc. Natl. Acad. Sci. USA, 95(20): 11709-11714, 1998.
  • V. Joukov, K. Pajusola, A. Kaipainen, D. Chilov, I. Lahtinen, E. Kukk et al., A novel vascular endothelial growth factor, VEGF-C, is a ligand for the flt4 ( VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J., 15(7): 1751, 1996.
  • M.G. Achen, M. Jeltsch, E. Kukk, T. Makinen, A. Vitali, A.F. Wilks et al., Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (flk1) and VEGF receptor 3 (flt4). Proc. Natl. Acad. Sci. USA, 95(2): 548-553, 1998.
  • B. Olofsson, M. Jeltsch, U. Eriksson and K. Alitalo, Current biology of VEGF-B and VEGF-C. Curr. Opin. Biotechnol., 10(6): 528-535, 1999.
  • Y. Cao, P. Linden, J. Farnebo, R. Cao, A. Eriksson, V. Kumar et al., Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA, 95(24): 14389-14394, 1998.
  • L. Marconcini, S. Marchio, L. Morbidelli, E. Cartocci, A. Albini, M. Ziehe et al., C-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc. Natl. Acad. Sci. USA, 96(17): 9671-9676, 1999.
  • E.Y. Yang and H.L. Moses, Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell. Biol, 111(2): 731-741, 1990.
  • M. Frater-Schroder, G. Muller, W. Birchmeier and P. Bohlen, Transforming growth factor-beta inhibits endothelial cell proliferation. Biochem. Biophys. Res. Commun., 137(1): 295-302, 1986.
  • E.J. Battegay, J. Rupp, L. Iruela-Arispe, E.H. Sage and M. Pech, PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF betareceptors. J. Cell. Biol, 125(4): 917-928, 1994.
  • E.J. Battegay, Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects. J. MoI. Med., 73(7): 333-346, 1995.
  • P. Carmeliet, Fibroblast growth factor-1 stimulates branching and survival of myocardial arteries: A goal for therapeutic angiogenesis? [editorial; comment]. Circ. Res., 87(3): 176-178, 2000.
  • D.L. Miller, S. Ortega, O. Bashayan, R. Basch and C. Basilico, Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. MoI. Cell. Biol., 20(6): 2260-2268, 2000.
  • R.M. Strieter, P.J. Polverini, S.L. Kunkel, D.A. Arenberg, M.D. Burdick, J. Kasper et al., The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem., 270(45): 27348-27357, 1995.
  • J.A. Belperio, M.P. Keane, D.A. Arenberg, C.L. Addison, J.E. Ehlert, M.D. Burdick et al., CXC chemokines in angiogenesis. J. Leukoc. Biol., 68(1): 1-8, 2000.
  • V. Jouan, X. Canron, M. Alemany, J.P. Caen, G. Quentin, J. Plouet et al., Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood, 94(3): 984-993, 1999.
  • C.L. Addison, T.O. Daniel, M.D. Burdick, H. Liu, J.E. Ehlert, Y.Y. Xue et al., The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR(+) CXC chemokine-induced angiogenic activity. J. Immunol., 165(9): 5269-5277, 2000.
  • M. Hebbar, J.P. Peyrat, L. Homez, RY. Matron, E. Hachulla and B. Devulder, Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum., 43(4): 889-893, 2000.
  • R. Lucas, L. Holmgren, I. Garcia, B. Jimenez, S.J. Mandriota, F. Borlat et al., Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood, 92(12): 4730-4741, 1998.
  • M.S. O'Reilly, L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, M. Moses et al., Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79(2): 315-328, 1994.
  • L. Claesson-Welsh, M. Welsh, N. Ito, B. Anand-Apte, S. Soker, B. Zetter et al., Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc. Natl. Acad. Sci. USA, 95(10): 5579-5583, 1998.
  • M.S. O'Reilly, D. Wiederschain, W.G. Stetler-Stevenson, J. Folkman and M.A. Moses, Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J. Biol. Chem., 274(41): 29568-29571, 1999.
  • L.A. Cornelius, L.C. Nehring, E. Harding, M. Bolanowski, H.G. Welgus, D.K. Kobayashi et al., Matrix metalloproteinases generate angiostatin: Effects on neovascularization. J. Immunol, 161(12): 6845-6852, 1998.
  • A. Pozzi, P.E. Moberg, L.A. Miles, S. Wagner, P. Soloway and H.A. Gardner, Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc. Natl. Acad. Sci. USA, 97(5): 2202-2207, 2000.
  • M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, WS. Lane et al., Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell, 88(2): 277-285, 1997.
  • U. Felbor, L. Dreier, R.A. Bryant, H.L. Ploegh, B.R. Olsen and W Mothes, Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J., 19(6): 1187-1194, 2000.
  • W. Wen, M.A. Moses, D. Wiederschain, J.L. Arbiserand J. Folkman, The generation of endostatin is mediated by elastase. Cancer Res., 59(24): 6052-6056, 1999.
  • Y.M. Kirn, J. W Jang, O.H. Lee, J. Yeon, E.Y. Choi, K. W Kirn et al., Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res., 60(19): 5410-5413, 2000.
  • P.C. Brooks, S. Stromblad, L.C. Sanders, T.L. von Schalscha, R.T. Aimes and W.G. Stetler-Stevenson et al., Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v. beta 3. Cell, 85(5): 683-693, 1996.
  • J. Korhonen, J. Partanen, E. Armstrong, A. Vaahtokari, K. Elenius, M. Jalkanen et al., Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood, 80(10): 2548-2555, 1992.
  • S. Davis, T.H. Aldrich, P.F. Jones, A. Acheson, D.L. Compton, V. Jain et al., Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 87(7): 1161-1169, 1996.
  • C. Suri, P.F. Jones, S. Patan, S. Bartunkova, RC. Maisonpierre, S. Davis et al., Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell, 87(7): 1171-1180, 1996.
  • M. Detmar, L.F. Brown, M. R Schon, B.M. Elicker, R Velasco, L. Richard et al., Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J. Invest. Dermatol., 111(1): 1-6, 1998.
  • C. Suri, J. McClain, G. Thurston, D.M. McDonald, H. Zhou, E.H. Oldmixon et al., Increased vascularization in mice overexpressing angiopoietin-1. Science, 282(5388): 468-471, 1998.
  • G. Thurston, J.S. Rudge, E. Ioffe, H. Zhou, L. Ross, S.D. Croll et al., Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med., 6(4): 460-463, 2000.
  • I. Baumgartner, G. Rauh, A. Pieczek, D. Wuensch, M. Magner, M. Kearney et al., Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann. Intern. Med., 132(11): 880-884, 2000.
  • A.L. Wong, Z.A. Haroon, S. Werner, M.W. Dewhirst, C.S. Greenberg, K.G. Peters, Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ. Res., 81(4): 567-574, 1997.
  • R Lindahl, B. R Johansson, R Leveen and C. Betsholtz, Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science, 277(5323): 242-245, 1997.
  • L.E. Benjamin, I. Hemo and E.A. Keshet, A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development, 125(9): 1591-1598, 1998.
  • D.Y. Li, L.K. Sorensen, B.S. Brooke, L.D. Urness, E.C. Davis, D.G. Taylor et al., Defective angiogenesis in mice lacking endoglin. Science, 284(5419): 1534-1537, 1999.
  • H.H. Marti and W. Risau, Angiogenesis in ischemic disease. Thromb Haemost, 82(Suppl 1): 44-52 1999.
  • M. Simons, R.O. Bonow, N.A. Chronos, D.J. Cohen, F.J. Giordano, H.K. Hammond et al., Clinical trials in coronary angiogenesis: Issues, problems, consensus: An expert panel summary. Circulation, 102(11): E73-E86, 2000.
  • E. Keshet and S.A. Ben Sasson, Anticancer drug targets: Approaching angiogenesis. J. Clin Invest, 104(11): 1497-1501, 1999.
  • R Carmeliet and R.K. Jain, Angiogenesis in cancer and other diseases. Nature, 407(6801): 249-257 2000.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.